NGS solutions that help simplify your journey to answers in hemato-oncology research
December 5, 2020
Amy Carroll, PhD
Director, North America Medical Affairs, NGS and Oncology
Thermo Fisher Scientific
This workshop will highlight our latest NGS solutions for hemato-oncology research testing. See the Oncomine Myeloid Assay GX on the revolutionary Ion Torrent Genexus System, the first NGS solution that can simultaneously profile all relevant myeloid DNA mutations and RNA fusion transcripts and deliver results in a single day.
We will also feature our latest immune repertoire assays for sequencing the B-cell and T-cell immunoglobulin receptors. These solutions offer breakthrough capabilities for assessing clonality and detecting rare clones in lymphoid neoplasm samples.